WALTHAM, Mass. & SAN DIEGO--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, ...
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. is showcasing its latest innovations in cancer research at the AACR Annual Meeting 2026, to be held in San Diego, April 17-22. The Company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results